315.78MMarket Cap-1.58P/E (TTM)
3.030High3.020Low3.70MVolume3.025Open3.030Pre Close11.19MTurnover3.86%Turnover RatioLossP/E (Static)104.39MShares9.74552wk High-1.94P/B290.19MFloat Cap2.30052wk Low--Dividend TTM95.93MShs Float42.410Historical High--Div YieldTTM0.33%Amplitude2.300Historical Low3.024Avg Price1Lot Size
Revance Therapeutics Stock Forum
Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement
Crown Laboratories and Revance Therapeutics (NASDAQ: RVNC) have announced an amended merger agreement where Crown will acquire all outstanding Revance shares for $3.10 per share in cash through a tender offer. The amendment comes after several developments, including Revance's settlement with Teoxane regarding distribution agreements and revised brand guidelines, which are expect...
📊⚡️📊
No comment yet